COMPARISON OF THERAPEUTIC EFFICACY AND HOST TOXICITY OF 2 DIFFERENT I-131-LABELLED ANTIBODIES AND THEIR FRAGMENTS IN THE GW-39 COLONIC-CANCER XENOGRAFT MODEL

被引：66

作者：

BLUMENTHAL, RD ^{[1
]}

SHARKEY, RM ^{[1
]}

KASHI, R ^{[1
]}

GOLDENBERG, DM ^{[1
]}

机构：

[1] UNIV MED & DENT NEW JERSEY,CTR MOLEC MED & IMMUNOL,1 BRUCE ST,NEWARK,NJ 07103

来源：

关键词：

D O I：

10.1002/ijc.2910440218

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：292 / 300

页数：9

共 46 条

[1] Anderson R E, 1976, Adv Immunol, V24, P215, DOI 10.1016/S0065-2776(08)60331-4
[2] APPLEBAUM FR, 1987, NATL CANCER I MONOGR, V3, P67
[3] BADGER CC, 1985, CANCER RES, V45, P1536
[4] REDUCTION BY ANTI-ANTIBODY ADMINISTRATION OF THE RADIOTOXICITY ASSOCIATED WITH I-131-LABELED ANTIBODY TO CARCINOEMBRYONIC ANTIGEN IN CANCER RADIOIMMUNOTHERAPY
BLUMENTHAL, RD
SHARKEY, RM
SNYDER, D
GOLDENBERG, DM
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (03) : 194 - 199
[5] BLUMENTHAL RD, 1988, CANCER RES, V48, P5403
[6] BLUMENTHAL RD, 1989, IN PRESS CANCER RES
[7] BROWN BA, 1987, CANCER RES, V47, P3577
[8] Brownell GL, 1968, J NUCL MED S1, V9, P27
[9] BUCHEGGER F, 1986, CANCER, V58, P655, DOI 10.1002/1097-0142(19860801)58:3<655::AID-CNCR2820580310>3.0.CO
[10] 2-E